MedTrace Logo

Efficacy and Safety of Immersive Virtual Reality for Post-stroke Cognitive Impairment

NCT06704360 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-11-26

No results posted yet for this study

Summary

This is a single-blind randomized controlled trial to evaluate the efficacy and safety of immersive virtual reality for post-stroke cognitive impairment.

Conditions

Interventions

DEVICE

immersive VR pathfinding training

Pathfinding training with immersive VR.

OTHER

Occupational therapy

Only receive conventional cognitive training group

Sponsors & Collaborators

  • Dingqun Bai

    lead OTHER

Principal Investigators

  • Dingqun Bai · First Affiliated Hospital of Chongqing Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2025-11-01
Completion
2025-12-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06704360 on ClinicalTrials.gov